Grapheal
PrivateLast Round
Grant
Feb 17, 2026
Total Funding Raised
$3.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Grapheal operates in Healthcare & Life Sciences and is based in Grenoble. Its latest recorded funding round was a Grant round in February 2026.
Grapheal is a health technology and advanced manufacturing company that develops and manufactures flexible, graphene-based sensing systems for environmental, industrial, and healthcare markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Sensors, Environmental Monitoring
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grapheal Comparables
Compare Grapheal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GraphWear Technologies Inc. | 78% | |
| Xsensio | 77% | |
| Ohmedics Ltd | 76% |
For institutional investors. Book with your work email.
Grapheal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2026 | ||||
| Grant | Feb 12, 2025 | ||||
| Grant | Oct 6, 2022 | ||||
| Seed | Feb 9, 2021 | ||||
| Grant | Nov 25, 2020 | ||||
Grant | Jul 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Grapheal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Électricité de France | Grant |
| Ministry of Higher Education and Research | Grant |
| EIT Health | Grant |
| National Academy of Medicine | Grant |
| ADEME - Agence de la transition écologique | Grant |
| Johnson & Johnson Innovation - JJDC | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 22, 2026
Grew 38% QoQ from 8 to 11 employees.
- Feb 17, 2026
Received grant funding from the European Innovation Council.
For institutional investors. Book with your work email.
Grapheal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Grapheal's valuation, stock price, and market status.
Is Grapheal a public or private company?
Grapheal is a private company.
What is the current stock price of Grapheal?
Grapheal is a private company, so its shares have no public market price. Caplight tracks Grapheal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Grapheal worth (valuation)?
Valuation information for Grapheal is not publicly available.
Can I buy Grapheal stock?
Grapheal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Grapheal's last funding round?
Grapheal's most recent funding round was Grant on February 17, 2026.
Who are the main investors in Grapheal?
Key investors in Grapheal include European Innovation Council Fund, Électricité de France, Ministry of Higher Education and Research, EIT Health, National Academy of Medicine.
Will Grapheal IPO soon?
No public IPO plans have been announced for Grapheal.
How can I track Grapheal secondary market activity?
Caplight tracks bids, offers, and trades in Grapheal's shares on secondary markets.